Evidence for Cell-Mediated Immunity and Specific Suppressor T Lymphocyte Dysfunction in Graves’ Disease and Diabetes Mellitus*
- 1 October 1983
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 57 (4) , 700-705
- https://doi.org/10.1210/jcem-57-4-700
Abstract
Migration inhibition of purified peripheral T lymphocytes in response to pancreatic islet cell antigen or thyroid antigen was used to study cell-mediated immune mechanisms in patients with diabetes mellitus (IDDM) and Graves’ disease (GD). In response to islet cell antigen, T lymphocytes of subjects with IDDM for less than 3 yr exhibited migration inhibition, whereas those of normal subjects, noninsulin dependent diabetics, and subjects with IDDM for longer than 3 yr did not. Admixture of T lymphocytes from normal subjects with T lymphocytes from patients with IDDM for less than 3 yr substantially ameliorated the migration inhibition of the IDDM subjects to islet cell antigen. Migration of T lymphocytes from GD subjects was markedly inhibited by thyroid antigen and marginally inhibited by islet cell antigen. Admixture of GD T lymphocytes significantly ameliorated the migration inhibition of IDDM T lymphocytes to islet cell antigen, despite sensitization to thyroid antigen of the GD T lymphocytes. We conclude: 1) sensitization to islet cell antigen in IDDM of recent onset is confirmed; 2) the ability of normal and GD T lymphocytes to ameliorate the migration inhibition of IDDM T lymphocytes strongly suggests correction of deficient suppressor T lymphocyte function; 3) the ability of GD T lymphocytes to ameliorate migration inhibition of IDDM T lymphocytes to islet cell antigen is evidence for an antigen-specific rather than a generalized suppressor T lymphocyte defect in GD; and 4) similarly, the normalization of migration index of GD T lymphocytes in response to thyroid antigen by those IDDM T lymphocytes not sensitized to thyroid antigen is again evidence for an antigen-specific and not a generalized suppressor T lymphocyte defect in IDDM.Keywords
This publication has 16 references indexed in Scilit:
- Normal Immunoregulation of in Vitro Antibody Secretion in Autoimmune Thyroid Disease*Journal of Clinical Endocrinology & Metabolism, 1981
- Suppressor T-Lymphocyte Deficiency in Graves’ Disease and Hashimoto’s Thyroiditis*Journal of Clinical Endocrinology & Metabolism, 1981
- T-Lymphocyte Sensitization in Graves’ and Hashimoto’s Diseases Confirmed by an Indirect Migration Inhibition Factor Test*Journal of Clinical Endocrinology & Metabolism, 1981
- Sensitization of T-Lymphocytes in Graves’ and Hashimoto's Diseases*Journal of Clinical Endocrinology & Metabolism, 1980
- DEPRESSED SUPPRESSOR CELL-ACTIVITY IN PATIENTS WITH NEWLY DIAGNOSED INSULIN-DEPENDENT DIABETES-MELLITUS1980
- CLINICAL AND PATHOGENIC SIGNIFICANCE OF PANCREATIC-ISLET-CELL ANTIBODIES IN DIABETICS TREATED WITH ORAL HYPOGLYCÆMIC AGENTSThe Lancet, 1977
- Enhancement by Irradiated T Cells of Human Plasma Cell Production: Dissection of Helper and Suppressor Functions in VitroThe Journal of Immunology, 1977
- NEGATIVE ALLOGENEIC EFFECTS INVITRO .1. ALLOGENEIC T-CELLS MARKEDLY SUPPRESS SECONDARY ANTIBODY-FORMING CELL RESPONSE1977
- ISLET-CELL ANTIBODIES IN DIABETES MELLITUSThe Lancet, 1976
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951